| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6593336 |
Methods for treating irritable bowel syndrome |
Jul. 15, 2003 |
| 6593338 |
3-substituted 2,7-naphthyridin-1-yl derivatives |
Jul. 15, 2003 |
| 6589934 |
Kv2.1 antagonists |
Jul. 8, 2003 |
| 6589947 |
Use of corticotropin releasing factor antagonists and related compositions |
Jul. 8, 2003 |
| 6586418 |
Thrombin or factor Xa inhibitors |
Jul. 1, 2003 |
| 6579889 |
Substituted isonipecotyl derivatives as inhibitors of cell adhesion |
Jun. 17, 2003 |
| 6576651 |
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
Jun. 10, 2003 |
| 6576672 |
Polyamine treatment of neurological disorders |
Jun. 10, 2003 |
| 6565829 |
5-arylsulfonyl indoles useful for treating disease |
May. 20, 2003 |
| 6566354 |
Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
May. 20, 2003 |
| 6566369 |
Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients |
May. 20, 2003 |
| 6566381 |
Hetero-substituted metalloprotease inhibitors |
May. 20, 2003 |
| 6558649 |
Vitronectin receptor antagonist pharmaceuticals |
May. 6, 2003 |
| 6555132 |
Soft gelatin capsule manufacture |
Apr. 29, 2003 |
| 6555518 |
Gemcitabine as an immunosuppressive pharmaceutical agent |
Apr. 29, 2003 |
| 6555542 |
Sulfonamide lactam inhibitors of FXa and method |
Apr. 29, 2003 |
| 6552012 |
Heteroaryl diazabicycloalkanes, their preparation and use |
Apr. 22, 2003 |
| 6548481 |
Effectors of dipeptidyl peptidase IV |
Apr. 15, 2003 |
| 6548500 |
Reverse-turn mimetics and methods relating thereto |
Apr. 15, 2003 |
| 6548506 |
Benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them |
Apr. 15, 2003 |
| 6544565 |
Use of Valeriana for the treatment of Restless Leg Syndrome and related disorders |
Apr. 8, 2003 |
| 6544974 |
(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 8, 2003 |
| 6534491 |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
Mar. 18, 2003 |
| 6534492 |
Uracil substituted phenyl sulfamoyl carboxamides |
Mar. 18, 2003 |
| 6531464 |
Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives |
Mar. 11, 2003 |
| 6528526 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Mar. 4, 2003 |
| 6525026 |
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
Feb. 25, 2003 |
| 6525040 |
Cyclic organoselenium compounds, their preparation and their uses |
Feb. 25, 2003 |
| 6525086 |
Compounds, their preparation and use |
Feb. 25, 2003 |
| 6525099 |
N-substituted sulfonamide derivatives |
Feb. 25, 2003 |
| 6521609 |
Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes |
Feb. 18, 2003 |
| 6521610 |
4-Haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides |
Feb. 18, 2003 |
| 6517836 |
Nitrophenylaziridine compounds and their use as prodrugs |
Feb. 11, 2003 |
| 6514963 |
Methods for the inhibition of egg production in trematodes |
Feb. 4, 2003 |
| 6514983 |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
Feb. 4, 2003 |
| 6515024 |
Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
Feb. 4, 2003 |
| 6511669 |
Cosmetic compositions containing an anionic hydroxyalkyl ether surfactant and a cationic polymer, and uses thereof |
Jan. 28, 2003 |
| 6511971 |
Substituted perhalogenated phthalocyanines |
Jan. 28, 2003 |
| 6511986 |
Method of treating estrogen receptor positive carcinoma |
Jan. 28, 2003 |
| 6512004 |
Promoters of neural regeneration |
Jan. 28, 2003 |
| 6509334 |
Cyclocarbamate derivatives as progesterone receptor modulators |
Jan. 21, 2003 |
| 6506743 |
2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides |
Jan. 14, 2003 |
| 6506772 |
Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands |
Jan. 14, 2003 |
| 6503891 |
Water emulsifiable formulations |
Jan. 7, 2003 |
| 6503897 |
Antibacterial agents |
Jan. 7, 2003 |
| 6498155 |
Methods of treating thrombocytopenia |
Dec. 24, 2002 |
| 6495522 |
Substituted alpha-hydroxy acid caspase inhibitors and the use thereof |
Dec. 17, 2002 |
| 6495537 |
Method for inhibition of photocarcinogenesis or photoimmunosuppression using niacin |
Dec. 17, 2002 |
| 6495593 |
Compositions for preventing or treating adverse physiological effects associated with cardiac disease |
Dec. 17, 2002 |
| 6491951 |
Soluble compositions of toremifene |
Dec. 10, 2002 |
|
|
|
